Amy Mahery
Net worth: 6 $ as of 31/08/2026
Net worth: 6 $ as of 31/08/2026
Amy Mahery is currently an Independent Director at CNS Pharmaceuticals, Inc. since 2024.
Formerly, Ms. Mahery was Chief Commercial Officer at Roivant Sciences Ltd. from 2022 to 2024 and Senior Vice President at EMD Serono, Inc. from 2021 to 2022.
Ms. Mahery completed undergraduate education at Trinity College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/08/2026 | 1 ( 0% ) | 6 $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Director/Board Member | 18/01/2024 |
| Companies | Position | End |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01/12/2024 |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | 01/07/2022 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Trinity College
Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions